Les Sulewski
Stock Analyst at Truist Securities
(0.19)
# 4,230
Out of 4,884 analysts
12
Total ratings
18.18%
Success rate
-29.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $25 | $17.01 | +46.97% | 1 | May 28, 2025 | |
| PCRX Pacira BioSciences | Upgrades: Hold | $8 → $25 | $23.22 | +7.67% | 6 | Jan 30, 2025 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $8.42 | +42.52% | 3 | Oct 2, 2024 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $40 → $42 | $30.35 | +38.39% | 2 | Aug 9, 2024 |
Teva Pharmaceutical Industries
May 28, 2025
Initiates: Buy
Price Target: $25
Current: $17.01
Upside: +46.97%
Pacira BioSciences
Jan 30, 2025
Upgrades: Hold
Price Target: $8 → $25
Current: $23.22
Upside: +7.67%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $8.42
Upside: +42.52%
Collegium Pharmaceutical
Aug 9, 2024
Maintains: Buy
Price Target: $40 → $42
Current: $30.35
Upside: +38.39%